Results 31 to 40 of about 33,409 (329)

Survival After Combining Stereotactic Body Radiation Therapy and Tyrosine Kinase Inhibitors in Patients With Metastatic Renal Cell Carcinoma

open access: yesFrontiers in Oncology, 2021
BackgroundStereotactic body radiation therapy (SBRT) and tyrosine kinase inhibitors (TKIs) are effective treatments for metastatic renal cell carcinoma, but data on combining these two modalities are scarce.
Yang Liu   +8 more
doaj   +1 more source

Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients

open access: yesRadiation Oncology, 2020
Local ablative treatment strategies are frequently offered to patients diagnosed with oligometastatic disease. Stereotactic body radiotherapy (SBRT), as ablative treatment option, is well established for lung and liver metastases, whereas for isolated ...
L. König   +12 more
semanticscholar   +1 more source

First-Line Anlotinib Combined with Stereotactic Body Radiation Therapy for an Octogenarian with Pulmonary Carcinosarcoma

open access: yesCancer Management and Research, 2022
Long Liang,1,* Taiyu Chen,2,* Tao Ren,3 Mian Mao,4 Keli Wang,5 Chunhan Tang,2 Juan Xiao,1 Hongyuan Jia,1 Wenli Chen,1 Qifeng Wang,1 Tao Li1 1Department of Radiation Oncology, Sichuan Cancer Hospital and Institution, Sichuan Cancer Center, School ...
Liang L   +10 more
doaj  

Stereotactic Body Radiotherapy (SBRT) for liver metastasis – clinical outcomes from the international multi-institutional RSSearch® Patient Registry

open access: yesRadiation Oncology, 2018
Stereotactic body radiotherapy (SBRT) is an emerging treatment option for liver metastases in patients unsuitable for surgery. We investigated factors associated with clinical outcomes for liver metastases treated with SBRT from a multi-center ...
A. Mahadevan   +9 more
semanticscholar   +1 more source

Novalis Tx radiosurgical platform experience in National Medical Research Centre for Oncology of the Ministry of Health of Russian

open access: yesЮжно-Российский онкологический журнал, 2020
Purpose of the study. The primary study presents an analysis of the results of stereotactic radiosurgery (SRS) and hypofractionated stereotactic radiotherapy (SRBT) of extra — and intracranial tumors obtained during four years of observation at «National
O. I. Kit   +7 more
doaj   +1 more source

Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Spine Metastases: An Overview

open access: yesFrontiers in Oncology, 2019
The oligometastatic state is hypothesized to represent an intermediary state of cancer between widely metastatic disease and curable, localized disease.
K. L. Zeng   +5 more
semanticscholar   +1 more source

The role of stereotactic radiotherapy in the treatment of the local recurrence of colorectal cancer: A case report [PDF]

open access: yesArchive of Oncology
Colorectal cancer is one of the most common malignant diseases worldwide. A multidisciplinary approach to treatment involves surgery and chemotherapy, while radiotherapy is used in the treatment of tumors localized in the pelvis.
Radosavljević Kristina   +5 more
doaj   +1 more source

ROBOTIC RADIOSURGERY AS A TREATMENT OPTION FOR PATIENTS WITH LOCALIZED PROSTATE CANCER

open access: yesСибирский онкологический журнал, 2016
The article analyzed the immediate and long-term results of treatment of patients with prostate cancer receiving treatment method – robotic radiosurgery.
I. A. Vazhenin   +4 more
doaj   +1 more source

A Histologic Basis for the Efficacy of SBRT to the lung [PDF]

open access: yesJournal of Thoracic Oncology, 2017
Stereotactic body radiation therapy (SBRT) is the standard of care for medically inoperable patients with early-stage NSCLC. However, NSCLC is composed of several histological subtypes and the impact of this heterogeneity on SBRT treatments has yet to be established.We analyzed 740 patients with early-stage NSCLC treated definitively with SBRT from ...
Chandana A. Reddy   +12 more
openaire   +3 more sources

Systemic therapy‐based split‐course stereotactic body radiation therapy

open access: yesPrecision Radiation Oncology, Volume 6, Issue 4, Page 306-320, December 2022., 2022
Abstract Purpose Given the therapeutic toxicity of concurrent chemoradiotherapy, the dose of chemotherapy is always limited. Hence, the question of how to administer adequate chemotherapy to synchronize stereotactic body radiation therapy (SBRT) treatment strategy for maximizing the benefits of neoadjuvant therapy to improve prognosis is a challenging ...
Rong Zheng   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy